Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Rybelsus (oral diabetes medication): DKK 23.3 billion (USD 3.38 billion), also demonstrating strong growth with a 26% increase year-over-year
Order1kg Purity0.99 Cas No2381089-83-2 Supply Ability10T Update time2026-06-25 Shandong Hanjiang Chemical Co., Ltd VIP3Y China show more Enterprise Verified Business Bank account Basic Contact Infomation Business Address Trade Company Chemical Properties show more Company Profile Introduction You may like Recommended supplier Send Inquriy
Akkermansia was chosen because it is naturally present in the human gut microbiome and has been studied for its role in gut barrier function, microbial diversity, and the bodys natural GLP-1 activity
It is currently in the Phase 3 LIVERAGE trials, which specifically target patients with F2-F3 fibrosis and includes a program for cirrhosis
NICE NG28 advises considering a GLP-1 receptor agonist in preference to a sulphonylurea when weight loss or avoidance of hypoglycaemia is a priority, though sulphonylureas remain appropriate options in selected patients
US$ 25.90
US$ 24.44
US$ 27.60
US$ 21.60
US$ 23.95
US$ 27.87
US$ 21.41
US$ 20.02
US$ 24.36
US$ 25.90
